There has been a significant shift in the fundamentals for Immunogen, Inc. (NASDAQ:IMGN)
Immunogen, Inc. (NASDAQ:IMGN) shares traded 0.20% higher at $29.71 on Wall Street last session. In accordance with the data, 14 analysts cover Immunogen, Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $31.26 and a low of $19.00, we find […]
A breakdown of the latest mutual funds holding Immunogen, Inc. (IMGN)
Stocks of Immunogen, Inc. (NASDAQ:IMGN) traded higher last session on Wall Street, down -0.34% to $29.22. According to the data, Immunogen, Inc. (NASDAQ:IMGN) has 14 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $31.26 and a low […]
When is the right time to cash out of Immunogen, Inc. [IMGN] stock?
Stocks of Immunogen, Inc. (NASDAQ:IMGN) traded higher last session on Wall Street, up 0.50% to $16.06. According to the data, Immunogen, Inc. (NASDAQ:IMGN) has 17 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $28.00 and a low […]
Immunogen, Inc. (IMGN) Price Aside, IMGN Fundamentals Booming Beyond Compare
The price of Immunogen, Inc. (NASDAQ:IMGN) shares last traded on Wall Street rose 3.34% to $16.11. Based on available information, 16 analysts follow Immunogen, Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $28.00 and a low of $14.00, we […]
Does Immunogen, Inc. (NASDAQ:IMGN) warrant a purchase right now? What to Consider Before Making a Decision
Immunogen, Inc. (NASDAQ:IMGN) shares traded -0.76% lower at $15.64 on Wall Street last session. In accordance with the data, 16 analysts cover Immunogen, Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $28.00 and a low of $14.00, we find […]
Does Immunogen, Inc. (NASDAQ:IMGN) warrant a purchase right now? What to Consider Before Making a Decision
Immunogen, Inc. (NASDAQ:IMGN) shares traded 5.10% higher at $16.29 on Wall Street last session. In accordance with the data, 14 analysts cover Immunogen, Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $28.00 and a low of $14.00, we find […]
Does Immunogen, Inc. (NASDAQ:IMGN) presents a BIG investment opportunity?
Stocks of Immunogen, Inc. (NASDAQ:IMGN) traded higher last session on Wall Street, up 1.42% to $15.00. According to the data, Immunogen, Inc. (NASDAQ:IMGN) has 13 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $27.00 and a low […]
Does Immunogen, Inc. (NASDAQ:IMGN) warrant a purchase right now? What to Consider Before Making a Decision
Immunogen, Inc. (NASDAQ:IMGN) shares traded 11.72% higher at $13.92 on Wall Street last session. In accordance with the data, 13 analysts cover Immunogen, Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $27.00 and a low of $13.00, we find […]
Can Immunogen Inc. (IMGN) stock recover despite sales dropping?
In yesterday’s Wall Street session, Immunogen Inc. (NASDAQ:IMGN) shares traded at $16.00, up 3.90% from the previous session. 12 analysts cover Immunogen Inc. (NASDAQ:IMGN), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $27.00 and a low of […]
The shares of ImmunoGen Inc. (IMGN) have recorded the market capitalization of 3.73B
ImmunoGen Inc. (NASDAQ:IMGN) shares traded 2.02% higher at $14.93 on Wall Street last session. In accordance with the data, 12 analysts cover ImmunoGen Inc. (NASDAQ:IMGN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $27.00 and a low of $13.00, we find […]
